A focus on “healthy” ultraprocessed foods is overstating benefits, legitimising industry narratives, and obscuring the priority of reducing overall consumption, argue Leandro Rezende and colleagues
Rezende et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: